Shares of Horizon Pharma PLC (NASDAQ:HZNP) and Radius Health Inc (NASDAQ:RDUS) each plunged more than 10% Thursday following disappointing clinical trial results. Let’s …
Horizon Pharma PLC (NASDAQ:HZNP) shareholders are having a rough morning after the drug maker announced that its Phase III STEADFAST trial of Actimmune in …
Horizon Pharma PLC (NASDAQ:HZNP) announced that a retrospective analysis of data from previous pivotal, randomized KRYSTEXXA® (pegloticase) clinical trials demonstrate that refractory chronic …
Horizon Pharma PLC (NASDAQ:HZNP) announced its third-quarter 2016 financial results today and confirmed its full-year 2016 GAAP net sales, non-GAAP adjusted net sales …
Horizon Pharma PLC (NASDAQ:HZNP) announced that Horizon Pharma, Inc. and Horizon Pharma USA, Inc.
Horizon Pharma PLC (NASDAQ:HZNP) announced that it has entered into a rebate agreement with Prime Therapeutics, which secures formulary status for its primary care …
Horizon Pharma PLC (NASDAQ:HZNP) announced this morning plans to acquire Raptor Pharmaceutical (NASDAQ:RPTP) for $800 million in cash, sending shares shooting up almost 10%. The deal …
Horizon Pharma PLC (NASDAQ:HZNP) and Raptor Pharmaceutical Corp. (NASDAQ:RPTP) announced the companies have entered into a definitive agreement under which Horizon Pharma will …
Horizon Pharma PLC (NASDAQ:HZNP), a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address …
Horizon Pharma PLC (NASDAQ:HZNP) just roared through its second-quarter earnings results. For the quarter, the drug maker came in with $257.
